Cloud Migration

NJBIZ honors Tevogen for its innovation, but can the biotech firm turn its ambitious multi-billion-dollar forecasts into reality? A deep dive.

A food-tech firm's pivot from quiet operator to public force reveals a savvy digital strategy, a key US acquisition, and a plan to dominate the 'better-for-you' market.

A tech-enabled CRO enrolled 550+ oncology patients in six months, a feat that signals a major disruption to the slow, costly drug development process.

WEP's deployment of 700 inspection systems in Missouri showcases its execution, but can it leverage this win in a competitive multi-billion dollar market?

Wrapbook's acquisition of scheduling platform Cinapse promises to end decades of fragmented workflows, creating a single system for planning and payroll.

An unsolicited bid from Paramount Skydance challenges Netflix's deal for WBD, sparking a high-stakes war for Hollywood's most iconic content library.

A nonprofit's anniversary reveals a powerful brand strategy: using data and free software to find families for 13,000+ children lost in the system.

Nova Era Labs promises to revolutionize AI education with virtual labs. But in a market of giants, can it deliver on its bold claims of workforce readiness?

The ADA’s new standards push for tech from day one and holistic care, but can the system deliver this innovative future to every patient?

Lumen Technologies is overhauling its balance sheet. Is this a savvy move for AI dominance or a risky gamble for the recovering telecom giant?

With a fresh $62M in funding, WELLSTAR is accelerating its AI and acquisition strategy ahead of a planned 2026 spinout, aiming to rewire Canadian healthcare.

A Swiss firm claims a CHF 480M raise and a $300M tech fund, but a closer look reveals a company with virtually no verifiable corporate footprint.

Emera renewed its C$600M equity program. We dive into the $20B plan driving this move and what it means for the future of energy grids and investors.

Healthcare tech firm StaffDNA’s title sponsorship of the Cure Bowl is more than a game—it's a calculated move blending branding with a cancer research mission.

A new alliance aims to streamline at-home diagnostics for pharma, but who is accountable for patient data and safety in this rapidly growing market?

A new partnership makes launching Global Capability Centers in India faster and more affordable, democratizing access to global talent and innovation.

As new laws bring clarity to digital currencies, WSPN is offering enterprises the tools to mint their own, accelerating a shift in global finance.

A PE firm's operational overhaul of a corporate carve-out leads to a strategic sale, highlighting the consolidation and tech trends reshaping security.

With new funding, Japan's Helical Fusion is racing to build a fusion plant by the 2030s. Can its unique stellarator technology win the clean energy race?

After its DMD drug trial sent shares soaring over 370%, Capricor Therapeutics is raising $75M. A look at the high-stakes strategy to fund a breakthrough.